Narhex hires Polish groups for drug development
18 July, 2005 by Ruth BeranSydney anti-viral drug developer Narhex Life Sciences (ASX:NLS) has signed separate manufacturing research agreements with two Polish organisations to reduce the cost and complexity of manufacturing its HIV protease inhibitor DG-35.
Cantor: why biomarkers will change medicine
18 July, 2005 by Ruth BeranIn five years time, biomarker analysis will deliver inexpensive, reliable tests for disease prognosis, delegates at a joint BioMelbourne and Australian Genome Research Facility event heard last week.
First US implant for Ventracor
18 July, 2005 by Ruth BeranSydney-based Ventracor (ASX:VCR) has implanted its first VentrAssist left ventricular assist system (LVAS) in the United States.
GM canola found in Australian consignment to Japan
15 July, 2005 by Graeme O'NeillRoutine tests by the Australian Barley Board have detected traces of genetically modified canola seed in a small consignment canola to Japan, triggering a strong reaction from anti-GM activist organisations.
Columna to receive AUD$3.5 million in QBF funding
15 July, 2005 by Helen SchullerSpinal implant technology company Columna has secured AUD$3.5 million in funding from Queensland BioCapital Funds for the development of spinal orthopaedic implants.
Biocomm and Monash University collaborate to establish CNSBio
15 July, 2005 by Ruth BeranBusiness development and seed finance company Biocomm Services and Monash University, through Monash Commercial, have established CNSBio -- a new Melbourne-based company focused on the research and treatment of pain associated with cancer and chronic inflammatory diseases.
Rockeby granted US patent for candida detection kit
14 July, 2005 by Helen SchullerRockeby biomed (ASX:RBY) has been awarded an additional US patent over its SysCan3 Hospital Test Kit for use in the diagnosis of candida infections such as systemic candidiasis and thrush.
GroPep clarifies its recurrent miscarriage project to the market
14 July, 2005 by Ruth BeranMedia speculation has forced Adelaide-based GroPep (ASX:GRO) to clarify its position on ethics committee approval for a clinical study of an infertility drug.
Relenza inventor Mark von Itzstein wins Adrien Albert Award
14 July, 2005 by Ruth BeranProf Mark von Itzstein has won the RACI's Adrien Albert Award for his contribution to medicinal chemistry through the design and development of anti-influenza virus drug Relenza.
Novogen drug said to promote wound healing
11 July, 2005 by Ruth BeranA phase II trial conducted by Novogen (ASX:NRT) subsidiary Glycotex has found that its wound healing compound Glucoprime promotes healing in venous stasis ulcers.
New $2m gait research centre launched
11 July, 2005 by Ruth BeranFederal treasurer Peter Costello and Dame Elisabeth Murdoch today launched the $2 million Centre for Clinical Research Excellence (CCRE) in Gait Analysis and Rehabilitation at the Royal Children's Hospital, Melbourne.
Perth's OBJ claims progress on 'electronic' drug patch
08 July, 2005 by Helen SchullerDrug delivery company OBJ (ASX:OBJ) claims to have reached an advanced stage in the development of its coin-sized smart drug patch.
GTG boss reflects on 'unusual' license dispute
08 July, 2005 by Graeme O'NeillMutual fatigue, and the peculiar challenges involved in negotiating with New Zealand's research and health-service agencies, were behind the mediated settlement of the Auckland District Health Board's dispute with Melbourne biotech Genetic Technologies (ASX:GTG) over licensing fees for GTG's non-coding DNA gene testing and mapping technology in NZ.
Shoppers will decide on GM: industry
08 July, 2005 by Ruth BeranConsumer perception of genetic modification (GM) has a big impact on research and the products produced by the agricultural biotechnology industry, delegates at a BioMelbourne BioBreakfast have heard.
New Chinese bird flu strain: low risk to Aust
08 July, 2005 by Graeme O'NeillChinese scientists have traced the deaths of around 1500 migratory waterbirds, including geese, gulls and cormorants on isolated Qinghai Lake in western China to a new strain of the lethal H5N1 influenza virus , or 'bird flu'.
